China Biopsy Market Report 2024-2032: Chinese Government Releases 8 Year Plan for Cancer Prevention and Treatment, to Achieve 46.6% Five Year Survival Rate among Cancer Patients by 2030 [Y...
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
China's biopsy device Market share is expected to be almost US$ 1,059.41 Million by 2032 compared to US$ 574.31 Million in 2023. The industry is forecast to increase at a CAGR of 7.04% from 2024 to 2032. China's population demographics, disease incidence, and prevalence are the key factors driving the growth of the biopsy device market in China. According to figures from the National Bureau of Statistics (NBS), 1.40967 billion people lived in China in 2023. With 9.02 million births in 2023, the birth rate per thousand people was 6.39. The NIH publications state that China saw about 4,824,700 new cases of cancer in 2022 (2,533,900 male cases and 2,290,800 female cases). It also notes that 57.4% of all new cases of cancer were caused by the top five malignancies, which are lung cancer (1,060,600), colorectal cancer (517,100), thyroid cancer (466 100), liver cancer (367,700), and female breast cancer (357,200). In China, it is projected that 2,574,200 people will lose their lives to
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now? [Yahoo! Finance]Yahoo! Finance
- Non-Viral Transfection Reagents Market worth USD 1,157.5 Million to 2031 - Exclusive Report by InsightAce Analytic [Yahoo! Finance]Yahoo! Finance
- $842.7 Million SDS Poly Acrylamide Gel Electrophoresis Market Forecast, 2030 - Featuring Profiles of 13 Companies Including Abcam, Bio-Rad Laboratories, GE Healthcare, and Thermo Fisher Scientific [Yahoo! Finance]Yahoo! Finance
- Africa Malaria Diagnostics Market Size, Share & Trends Analysis Report 2024-2030: Adaptation of the "Zero Malaria" Agenda to Bolster Growth with Increased Initiatives by Market Players and Private Investors [Yahoo! Finance]Yahoo! Finance
- Proteomics Market to Reach $161.9 billion, Globally, by 2035 at 14.2% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
BIO
Earnings
- 5/7/24 - Beat
BIO
Sec Filings
- 6/17/24 - Form 3
- 6/14/24 - Form 4
- 6/13/24 - Form 144
- BIO's page on the SEC website